
Tamriv-P 50mg/500mg Tablet
Marketer
East African (India) Overseas
Salt Composition
Tramadol (50mg) + Paracetamol (500mg)
Overview Tamriv-P 50mg/500mg Tablet
Combiflam-P 50mg/500mg tablets combine two analgesics to effectively manage moderate to severe pain. Adhere strictly to your physician's prescribed dosage and regimen. Consumption may be independent of meals, but if stomach discomfort arises, take with food. Consistent medication is crucial; discontinue only upon your doctor's instruction. Potential side effects, including nausea, vomiting, dry mouth, dizziness, and constipation, are typically mild and transient. Report any rash or allergic reaction promptly. Pregnant, planning pregnancy, or breastfeeding individuals should consult their doctor before commencing treatment.
Uses of Tamriv-P 50mg/500mg Tablet
Significant to intense discomfort
Major Benefits of Tamriv-P 50mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tamriv-P 50mg/500mg tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Tamriv-P 50mg/500mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Tamriv-P 50mg/500mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Tamriv-P 50mg/500mg Tablet whole; avoid crushing, chewing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
How Tamriv-P 50mg/500mg Tablet works:
Combiflam-50 contains Tramadol 50mg and Paracetamol 500mg, offering potent relief from intense pain. Tramadol, an opioid analgesic, diminishes pain sensation by interrupting pain signals to the brain. Paracetamol acts by inhibiting the production of pain-inducing chemical mediators.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Tamriv-P 50mg/500mg tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Tamriv-P 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Tamriv-P 50mg/500mg tablets appear to pose minimal risk. Available data from human studies indicate negligible infant harm. However, seek prompt medical attention should the infant display excessive lethargy, feeding difficulties, respiratory distress, or hypotonia.
DrivingUNSAFE
Driving ability may be impaired by the side effects of Tamriv-P 50mg/500mg tablets.
KidneyCAUTION
Patients with kidney impairment should use Tamriv-P 50mg/500mg Tablets cautiously, as dosage modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Tamriv-P 50mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Tamriv-P 50mg/500mg tablets are contraindicated in patients experiencing severe or active liver disease.
What if you forget to take Tamriv-P 50mg/500mg Tablet :
Should you forget to take a Tamriv-P 50mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tamriv-P 50mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
